NBP News

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

NovaBridge Biosciences Appoints Dr. Srishti Gupta as Chief Executive Officer

NovaBridge Biosciences Receives FDA Fast Track Designation for Givastomig in First-Line HER2-Negative Metastatic Gastric Cancer

NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference

NovaBridge to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference

NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value

Wellness Workdays Honors Nine Organizations with 2026 Best Wellness Employer Gold Certification

NovaBridge Reports Full Year 2025 Financial Results and Provides Business Update

NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer

NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study